Last-Minute Concessions in Germany’s Health Overhaul: Spousal Co-Pay Cut, Pharma Discounts Doubled

Germany's statutory health insurance reform gets last-minute changes: spouse co-insurance rate halved to 2.5%, child coverage extended to age 11, and pharmaceutical rebates doubled to 15.5% to close €18.8B gap.

Germany’s plan to shore up the statutory health insurance (GKV) system has been rewritten just days before a final parliamentary vote, after a wave of criticism from doctors, hospitals and insurers. Health Minister Nina Warken (CDU) scrapped or softened several of the most contested measures, shifting a larger share of the burden onto drugmakers while offering relief to families.

The biggest surprise concerns married couples. The proposed contribution rate for the non-working spouse’s free co-insurance was slashed from 3.5 percent to 2.5 percent, a significant reduction that makes the original plan far cheaper for many households. Children are also spared: free co-insurance will continue until they turn 11, rather than the previously planned cutoff at age seven. General contribution rates remain frozen at 17.5 percent (14.6 percent base plus 2.9 percent supplementary levy) until 2028.

To close a projected financing gap of €18.8 billion by 2027, Warken has turned squarely to the pharmaceutical industry. The manufacturer rebate on prescription drugs jumps from 7 percent to 15.5 percent, while a planned dynamic price discount has been dropped. Patients will feel the impact: co-payments for medicines rise by 50 percent, though the automatic annual increase initially proposed has been cancelled.

Additional federal money is also flowing in. For 2027, government subsidies to the GKV will reach €14.15 billion – roughly €1.4 billion more than originally budgeted. Beginning in 2030, an extra €750 million per year will be allocated to cover contributions for recipients of basic income support (Grundsicherung), a move intended to stabilise the system without overloading regular contributors.

Despite the last-minute tweaks, resistance has not faded. The package is due to pass the Bundestag this week, with the Bundesrat voting on Friday. But the German Medical Association’s president, Dr. Klaus Reinhardt, called the extra support for basic security recipients insufficient. He urged the government to postpone the entire reform and provide significantly higher federal funds. Hospital associations warned of potential site closures, and health insurers argued that the pharmaceutical industry, even with higher rebates, is still being let off too lightly.